Q--Investigating TTR Variants in Sickle Cell Disease Severity Using Olink Proteomi
ID: 75N92025Q00005Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Testing Laboratories and Services (541380)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/6bac586def1943d7ada1d5918546af30/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a project titled "Investigating TTR Variants in Sickle Cell Disease Severity Using Olink Proteomi." This presolicitation aims to explore the relationship between TTR variants and the severity of sickle cell disease, utilizing advanced proteomic analysis techniques. The services required fall under the NAICS code 541380, which pertains to Testing Laboratories and Services, and the PSC code Q301, indicating Medical Laboratory Testing. Interested parties can reach out to Moses T. Amawudah at moses.amawudah@nih.gov or call +1 301 451 2111 for further information regarding this opportunity.

    Point(s) of Contact
    AMAWUDAH, MOSES T
    +1 301 451 2111
    moses.amawudah@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Q--Investigating TTR Variants in Sickle Cell Disease Severity Using Olink Proteomi
    Currently viewing
    Presolicitation
    Similar Opportunities
    Q--Multi-scale Phenotyping of Heart Failure in Diverse Populations: from Precision
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for a project titled "Multi-scale Phenotyping of Heart Failure in Diverse Populations: from Precision Phenotyping to Population Inference." The objective of this procurement is to conduct comprehensive multi-scale phenotyping studies that address heart failure across diverse populations, emphasizing precision medicine and population health insights. This initiative is crucial for advancing understanding and treatment of heart failure, which significantly impacts public health. Interested parties can reach out to Noelle Decenzo at noelle.decenzo@nih.gov or call +1 301 402 5571 for further information regarding this sources sought notice.
    A--Resource for the Collection of Human Tissues, Cells, Biofluids and Epidemiologi
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking capability statements from organizations for a contract focused on the collection and evaluation of human tissues, cells, and biofluids from donors with epidemiologic profiles. This initiative aims to support molecular epidemiology studies related to various cancers, including lung, breast, liver, and pancreatic cancer, and involves tasks such as participant recruitment, biological specimen collection, and data processing while ensuring compliance with ethical regulations. The contract, anticipated to last five years, builds on efforts initiated in 1996 and emphasizes the importance of delivering viable tissues promptly and maintaining data confidentiality. Interested organizations, excluding the current provider, must submit their qualifications by February 18, 2025, and can contact Whitney D. Monkama at whitney.monkam@nih.gov or +1 240 276 5446 for further information.
    Long Read Sequencing Kits
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the procurement of Long Read Sequencing Kits, specifically Oxford Nanopore brand or equivalent items, to support research on neurodegenerative diseases. The acquisition aims to supply the Center for Alzheimer’s Disease and Related Dementias with kits that will facilitate the identification of causative genes linked to Alzheimer's Disease and related disorders, utilizing long-read sequencing technology. This procurement is critical for advancing research in understanding and treating neurodegenerative diseases, with an anticipated delivery of the first order by September 30, 2025, and options for additional orders in subsequent years. Interested vendors must submit their quotations by 12:00 p.m. EST on January 24, 2025, to Andrea Clay at amcgee@nida.nih.gov, referencing Solicitation Number 75N95025Q00095.
    SOURCES SOUGHT: Neurodegenerative Disease Scientific Data Analysis and Consulting Services
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small business sources for scientific data analysis and consulting services related to neurodegenerative diseases, particularly Alzheimer’s disease and related dementias. The objective of this procurement is to obtain advanced analytics support to integrate and analyze complex datasets, including imaging, genomic, and clinical data, to identify disease mechanisms and therapeutic targets. This initiative is crucial for enhancing research capabilities and ensuring data accessibility and interoperability within the scientific community. Interested parties must submit their capability statements by January 24, 2025, to Hashim Dasti at hashim.dasti@nih.gov, with no costs incurred by the government for responses.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services to support the development of drug products. The objective of this procurement is to ensure the delivery of high-quality formulated drug products for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic development. This opportunity encompasses a wide range of services, including formulation development, manufacturing under current Good Manufacturing Practices (cGMP), and necessary testing to meet regulatory standards. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can contact Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    Repository of Mouse Models for Down Syndrome
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for a contract titled "Repository of Mouse Models for Down Syndrome." The objective of this procurement is to produce, potentially acquire, maintain, and distribute mouse models specifically designed for cytogenetic research related to Down syndrome, which involves human trisomy for chromosome 21. These mouse models are crucial for advancing research in genetic disorders and improving understanding of Down syndrome. Interested small businesses are encouraged to reach out to Dana L. Harris at harrisd@mail.nih.gov or Kesha Williams at williamskl@mail.nih.gov for further details, as this opportunity is set aside for total small business participation under NAICS code 541714, with no specified funding amount or deadline mentioned in the overview.
    Biological Therapeutics Product Development Subject Matter Expert Consultants
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), is seeking proposals for consulting services from subject matter expert (SME) consultants to support the development of biological therapeutics. The objective of this procurement is to engage SMEs who can provide technical recommendations across various phases of drug discovery and development, including chemistry, regulatory affairs, and clinical trial design, particularly for novel therapeutics aimed at neurological disorders and rare genetic conditions. This initiative is crucial for advancing NIH drug discovery programs and ensuring that innovative therapeutic solutions progress efficiently to clinical evaluation. Interested vendors must submit their proposals by January 27, 2025, and can direct inquiries to Shayna Simpson at shayna.simpson@nih.gov or Kelly Dempsey at kelly.dempsey@nih.gov. The contract is expected to span one year with two optional extensions, and the anticipated performance period is from April 1, 2025, to March 30, 2026.
    Sebia Inc. Hydrasys 2 Reagents for the Department of Laboratory Medicine
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure Sebia Inc. Hydrasys 2 reagents through a sole-source contract for the Department of Laboratory Medicine. This acquisition aims to secure essential reagent kits, quality control materials, and supplies necessary for electrophoresis testing, which is critical for monitoring patients with B-cell malignancies and central nervous system diseases. The Sebia reagent kits are uniquely designed for compatibility with the existing Sebia Hydrasys 2 analyzers, ensuring high-quality patient care within the Chemistry Service. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by January 31, 2024, at 6:30 AM EST, as this is not a request for quotations.
    Personal Protective Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure Personal Protective Supplies through a sole source contract with Fisher Scientific Company, LLC. The requirement is for Personal Protective Equipment (PPE) essential for aseptic processing laboratories that manufacture cell-based and gene therapies for patients involved in clinical trials at the NIH Clinical Center. Timely supply of these PPE is critical, as any delays could adversely affect cell therapy production and patient care. Interested parties capable of providing similar products may submit a capability statement by January 25, 2025, at 12 PM to Tasha Lowe at lowet2@mail.nih.gov for consideration.
    Hardy Diagnostic Reagents and Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.